Cartesian Therapeutics, Inc. — Director's Dealing 2020

Jun 24, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2020-06-19

Reporting Person: BARABE TIMOTHY C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-19	Stock Option (Right to Buy)	$3.0	A	20000	Acquired	2030-06-18	Common Stock (20000.0)	Direct

Footnotes

F1: The option vests in full on the earlier of June 19, 2021 or the day immediately prior to the company's 2021 annual meeting of stockholders.